Skip to main content
. 2017 Sep 12;8:1130. doi: 10.3389/fimmu.2017.01130

Table 2.

Mass cytometry staining panel.

Marker Tag Clone Vendor
CD45 89Y HI30 Fluidigm
CD57 115In HCD57 BioLegend
CD196 (CCR6) 141Pr 11A9 BD Pharmingen
CD19 142Nd HIB19 Fluidigm
CD5 143Nd UCHT2 Biolegend
CD195 (CCR5) 144Nd NP-6G4 Fluidigm
CD4 145Nd RPA-T4 Fluidigm
CD8a 146Nd SK1 BioLegend
CD11c 147Sm Bu15 Fluidigm
CD31 148Nd WM59 BioLegend
CD278 (ICOS) 151Eu DX29 Fluidigm
αβTCR 152Sm IP26 BioLegend
CD3ε 154Sm UCHT1 Fluidigm
CD194 (CCR4) 155Gd 205410 R&D Systems
Vα2.3 156Gd F1 Thermo Scientific
CXCR3 157Gd G025H7 BioLegend
Vβ22 159Tb IMMU 546 Beckman Coulter Immunotech
CD28 160Gd CD28.2 BioLegend
CD161 161Dy HP-3G10 BioLegend
Ki-67 162Dy B56 Fluidigm
HLA-DR 163Dy L243 BioLegend
CD44 164Dy BJ18 BioLegend
CD127 165Ho A019D5 Fluidigm
CD27 167Er L128 Fluidigm
CD38 168Er HIT2 BioLegend
CD45RA 169Tm HI100 Fluidigm
CD152 (CTLA-4) 170Er 14D3 Fluidigm
CD279 (PD-1) 172Yb EH12.2H7 BioLegend
CD39 173Yb A1 BioLegend
CXCR5 174Yb 51505 R&D Systems
Cell-ID™ Intercalator-Ir (DNA) 191Ir Fluidigm
Cell-ID™ Intercalator-Ir (DNA) 193Ir Fluidigm
Cell-ID™ Cisplatin (Live–dead) 195Pt Fluidigm

CD, cluster of differentiation; CTLA-4, cytotoxic T lymphocyte-associated protein 4; CCR, C–C chemokine receptor; ICOS, inducible co-stimulatory molecule; PD-1, programmed cell death protein 1; CXCR, CXC chemokine receptor; TCR, T cell receptor; HLA-DR, human leukocyte antigen-antigen D related; Sm, samarium; Nd, neodymium; Er, erbium; Gd, gadolinium; Yb, ytterbium; Dy, dysprosium; Y, yttrium; Tm, thulium; In, indium; Ho, holmium; Gd, gadolinium; Pr, praseodymium; Eu, europium; Pt, platinum; Ir, iridium.

Fluidigm, South San Francisco, CA, USA; BioLegend, San Diego, CA, USA; BD Pharmingen, San Diego, CA, USA; R&D Systems Inc., Minneapolis, MN, USA; Thermo Scientific, Rockford, IL. USA; Beckman Coulter Immunotech, Marseille, France.